An investigation of PreMCI: Subtypes and longitudinal outcomes

David Loewenstein, Maria T. Greig, John A. Schinka, Warren Barker, Qian Shen, Elizabeth Potter, Ashok Raj, Larry Brooks, Daniel Varon, Michael Schoenberg, Jessica Banko, Huntington Potter, Ranjan Duara

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background/Aims: To investigate the clinical features and rates of progression of conditions that are not considered to be normal, but do not fulfill criteria for mild cognitive impairment (MCI). Methods: We longitudinally evaluated 269 elderly subjects who did not meet formal criteria for MCI at baseline but had: (1) a clinical history suggesting MCI without neuropsychological deficits (PreMCI-Clinical); or (2) neuropsychological deficits on one or more memory measures in conjunction with a negative clinical examination (amnestic PreMCI-NP) or were normal on both neuropsychological and clinical examination. Results: The rate of progression to MCI or dementia over an average of 2- to 3 years was 3.7% for no cognitive impairment subjects, whereas it was significantly greater for all PreMCI subtypes (22.0% for PreMCI-Clinical, 38.9% for amnestic PreMCI-NP subjects with two or more memory impairments). Among PreMCI subjects as a whole, lower baseline scores on object memory and category fluency tests were the best predictors of progression to MCI or dementia. Cardiovascular risk factors, Parkinsonian symptoms, and hippocampal atrophy were not associated with progression. Conclusion: Distinct PreMCI subtypes defined on the basis of clinical and neuropsychological evaluations were found to have distinct characteristics, but both subtypes demonstrated elevated risk for progression to MCI or dementia. Despite the lack of evidence of clinical impairment, subjects with neuropsychological deficits in two memory domains were particularly at increased risk for progression of their deficits.

Original languageEnglish
Pages (from-to)172-179
Number of pages8
JournalAlzheimer's and Dementia
Volume8
Issue number3
DOIs
StatePublished - May 1 2012

Fingerprint

Dementia
Cognitive Dysfunction
Atrophy

Keywords

  • Alzheimer's disease
  • Amnestic MCI
  • Hippocampal volumes
  • Memory impairment
  • Mild cognitive impairment
  • MRI
  • Neuropsychological tests
  • PreMCI

ASJC Scopus subject areas

  • Health Policy
  • Epidemiology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience
  • Developmental Neuroscience
  • Clinical Neurology

Cite this

Loewenstein, D., Greig, M. T., Schinka, J. A., Barker, W., Shen, Q., Potter, E., ... Duara, R. (2012). An investigation of PreMCI: Subtypes and longitudinal outcomes. Alzheimer's and Dementia, 8(3), 172-179. https://doi.org/10.1016/j.jalz.2011.03.002

An investigation of PreMCI : Subtypes and longitudinal outcomes. / Loewenstein, David; Greig, Maria T.; Schinka, John A.; Barker, Warren; Shen, Qian; Potter, Elizabeth; Raj, Ashok; Brooks, Larry; Varon, Daniel; Schoenberg, Michael; Banko, Jessica; Potter, Huntington; Duara, Ranjan.

In: Alzheimer's and Dementia, Vol. 8, No. 3, 01.05.2012, p. 172-179.

Research output: Contribution to journalArticle

Loewenstein, D, Greig, MT, Schinka, JA, Barker, W, Shen, Q, Potter, E, Raj, A, Brooks, L, Varon, D, Schoenberg, M, Banko, J, Potter, H & Duara, R 2012, 'An investigation of PreMCI: Subtypes and longitudinal outcomes', Alzheimer's and Dementia, vol. 8, no. 3, pp. 172-179. https://doi.org/10.1016/j.jalz.2011.03.002
Loewenstein, David ; Greig, Maria T. ; Schinka, John A. ; Barker, Warren ; Shen, Qian ; Potter, Elizabeth ; Raj, Ashok ; Brooks, Larry ; Varon, Daniel ; Schoenberg, Michael ; Banko, Jessica ; Potter, Huntington ; Duara, Ranjan. / An investigation of PreMCI : Subtypes and longitudinal outcomes. In: Alzheimer's and Dementia. 2012 ; Vol. 8, No. 3. pp. 172-179.
@article{7c3cc0be619341559619f81a188d690f,
title = "An investigation of PreMCI: Subtypes and longitudinal outcomes",
abstract = "Background/Aims: To investigate the clinical features and rates of progression of conditions that are not considered to be normal, but do not fulfill criteria for mild cognitive impairment (MCI). Methods: We longitudinally evaluated 269 elderly subjects who did not meet formal criteria for MCI at baseline but had: (1) a clinical history suggesting MCI without neuropsychological deficits (PreMCI-Clinical); or (2) neuropsychological deficits on one or more memory measures in conjunction with a negative clinical examination (amnestic PreMCI-NP) or were normal on both neuropsychological and clinical examination. Results: The rate of progression to MCI or dementia over an average of 2- to 3 years was 3.7{\%} for no cognitive impairment subjects, whereas it was significantly greater for all PreMCI subtypes (22.0{\%} for PreMCI-Clinical, 38.9{\%} for amnestic PreMCI-NP subjects with two or more memory impairments). Among PreMCI subjects as a whole, lower baseline scores on object memory and category fluency tests were the best predictors of progression to MCI or dementia. Cardiovascular risk factors, Parkinsonian symptoms, and hippocampal atrophy were not associated with progression. Conclusion: Distinct PreMCI subtypes defined on the basis of clinical and neuropsychological evaluations were found to have distinct characteristics, but both subtypes demonstrated elevated risk for progression to MCI or dementia. Despite the lack of evidence of clinical impairment, subjects with neuropsychological deficits in two memory domains were particularly at increased risk for progression of their deficits.",
keywords = "Alzheimer's disease, Amnestic MCI, Hippocampal volumes, Memory impairment, Mild cognitive impairment, MRI, Neuropsychological tests, PreMCI",
author = "David Loewenstein and Greig, {Maria T.} and Schinka, {John A.} and Warren Barker and Qian Shen and Elizabeth Potter and Ashok Raj and Larry Brooks and Daniel Varon and Michael Schoenberg and Jessica Banko and Huntington Potter and Ranjan Duara",
year = "2012",
month = "5",
day = "1",
doi = "10.1016/j.jalz.2011.03.002",
language = "English",
volume = "8",
pages = "172--179",
journal = "Alzheimer's and Dementia",
issn = "1552-5260",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - An investigation of PreMCI

T2 - Subtypes and longitudinal outcomes

AU - Loewenstein, David

AU - Greig, Maria T.

AU - Schinka, John A.

AU - Barker, Warren

AU - Shen, Qian

AU - Potter, Elizabeth

AU - Raj, Ashok

AU - Brooks, Larry

AU - Varon, Daniel

AU - Schoenberg, Michael

AU - Banko, Jessica

AU - Potter, Huntington

AU - Duara, Ranjan

PY - 2012/5/1

Y1 - 2012/5/1

N2 - Background/Aims: To investigate the clinical features and rates of progression of conditions that are not considered to be normal, but do not fulfill criteria for mild cognitive impairment (MCI). Methods: We longitudinally evaluated 269 elderly subjects who did not meet formal criteria for MCI at baseline but had: (1) a clinical history suggesting MCI without neuropsychological deficits (PreMCI-Clinical); or (2) neuropsychological deficits on one or more memory measures in conjunction with a negative clinical examination (amnestic PreMCI-NP) or were normal on both neuropsychological and clinical examination. Results: The rate of progression to MCI or dementia over an average of 2- to 3 years was 3.7% for no cognitive impairment subjects, whereas it was significantly greater for all PreMCI subtypes (22.0% for PreMCI-Clinical, 38.9% for amnestic PreMCI-NP subjects with two or more memory impairments). Among PreMCI subjects as a whole, lower baseline scores on object memory and category fluency tests were the best predictors of progression to MCI or dementia. Cardiovascular risk factors, Parkinsonian symptoms, and hippocampal atrophy were not associated with progression. Conclusion: Distinct PreMCI subtypes defined on the basis of clinical and neuropsychological evaluations were found to have distinct characteristics, but both subtypes demonstrated elevated risk for progression to MCI or dementia. Despite the lack of evidence of clinical impairment, subjects with neuropsychological deficits in two memory domains were particularly at increased risk for progression of their deficits.

AB - Background/Aims: To investigate the clinical features and rates of progression of conditions that are not considered to be normal, but do not fulfill criteria for mild cognitive impairment (MCI). Methods: We longitudinally evaluated 269 elderly subjects who did not meet formal criteria for MCI at baseline but had: (1) a clinical history suggesting MCI without neuropsychological deficits (PreMCI-Clinical); or (2) neuropsychological deficits on one or more memory measures in conjunction with a negative clinical examination (amnestic PreMCI-NP) or were normal on both neuropsychological and clinical examination. Results: The rate of progression to MCI or dementia over an average of 2- to 3 years was 3.7% for no cognitive impairment subjects, whereas it was significantly greater for all PreMCI subtypes (22.0% for PreMCI-Clinical, 38.9% for amnestic PreMCI-NP subjects with two or more memory impairments). Among PreMCI subjects as a whole, lower baseline scores on object memory and category fluency tests were the best predictors of progression to MCI or dementia. Cardiovascular risk factors, Parkinsonian symptoms, and hippocampal atrophy were not associated with progression. Conclusion: Distinct PreMCI subtypes defined on the basis of clinical and neuropsychological evaluations were found to have distinct characteristics, but both subtypes demonstrated elevated risk for progression to MCI or dementia. Despite the lack of evidence of clinical impairment, subjects with neuropsychological deficits in two memory domains were particularly at increased risk for progression of their deficits.

KW - Alzheimer's disease

KW - Amnestic MCI

KW - Hippocampal volumes

KW - Memory impairment

KW - Mild cognitive impairment

KW - MRI

KW - Neuropsychological tests

KW - PreMCI

UR - http://www.scopus.com/inward/record.url?scp=84860434161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860434161&partnerID=8YFLogxK

U2 - 10.1016/j.jalz.2011.03.002

DO - 10.1016/j.jalz.2011.03.002

M3 - Article

C2 - 22546351

AN - SCOPUS:84860434161

VL - 8

SP - 172

EP - 179

JO - Alzheimer's and Dementia

JF - Alzheimer's and Dementia

SN - 1552-5260

IS - 3

ER -